Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 3
1994 3
1995 3
1997 3
1998 3
2008 2
2009 1
2010 2
2011 3
2012 2
2013 4
2014 3
2015 3
2016 3
2017 4
2018 5
2019 3
2020 7
2021 11
2022 10
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.
Bendien SA, Kroes JA, van Hal LHG, Braunstahl GJ, Broeders MEAC, Oud KTM, Patberg KW, Smeenk FWJM, van Veen IHPAA, Weersink EJM, Fieten KB, Hashimoto S, van Veen A, Sont JK, van Huisstede A, van de Ven MJT, Langeveld B, Maitland-van der Zee AH, Ten Brinke A; Registry of Adult Patients With Severe Asthma for Optimal Disease Management Team. Bendien SA, et al. Among authors: weersink ejm. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2724-2731.e2. doi: 10.1016/j.jaip.2023.05.041. Epub 2023 Jun 7. J Allergy Clin Immunol Pract. 2023. PMID: 37295671
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making.
Otten J, van der Lans R, de Corso E, Dziadziulia K, Hilvering B, Weersink E, Bonini M, Hagemann J, Thaitrakool W, Montuori C, Klimek L, Reitsma S, Fokkens W. Otten J, et al. Among authors: weersink e. Expert Rev Clin Immunol. 2023 Jul-Dec;19(8):1041-1049. doi: 10.1080/1744666X.2023.2218617. Epub 2023 May 29. Expert Rev Clin Immunol. 2023. PMID: 37226507
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
Kos R, Brinkman P, Neerincx AH, Paff T, Gerritsen MG, Lammers A, Kraneveld AD, Heijerman HGM, Janssens HM, Davies JC, Majoor CJ, Weersink EJ, Sterk PJ, Haarman EG, Bos LD, Maitland-van der Zee AH; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group and the Amsterdam UMC Breath Research Group. Kos R, et al. Among authors: weersink ej. J Cyst Fibros. 2022 Jan;21(1):e28-e34. doi: 10.1016/j.jcf.2021.04.015. Epub 2021 May 18. J Cyst Fibros. 2022. PMID: 34016557 Free article. Review.
FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.
de Poel E, Spelier S, Hagemeijer MC, van Mourik P, Suen SWF, Vonk AM, Brunsveld JE, Ithakisiou GN, Kruisselbrink E, Oppelaar H, Berkers G, de Winter de Groot KM, Heida-Michel S, Jans SR, van Panhuis H, Bakker M, van der Meer R, Roukema J, Dompeling E, Weersink EJM, Koppelman GH, Blaazer AR, Muijlwijk-Koezen JE, van der Ent CK, Beekman JM. de Poel E, et al. Among authors: weersink ejm. J Cyst Fibros. 2023 May;22(3):548-559. doi: 10.1016/j.jcf.2023.03.004. Epub 2023 May 3. J Cyst Fibros. 2023. PMID: 37147251
Tobramycin and vestibulotoxicity: retrospective analysis of four cases.
Vonk SEM, Weersink EJM, Majoor CJ, Kemper EM; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group. Vonk SEM, et al. Among authors: weersink ejm. Eur J Hosp Pharm. 2022 Mar;29(e1):e88-e90. doi: 10.1136/ejhpharm-2020-002588. Epub 2021 Mar 22. Eur J Hosp Pharm. 2022. PMID: 33753422 Free PMC article.
Blood biomarkers in chronic airways diseases and their role in diagnosis and management.
van Bragt JJMH, Vijverberg SJH, Weersink EJM, Richards LB, Neerincx AH, Sterk PJ, Bel EHD, Maitland-van der Zee AH. van Bragt JJMH, et al. Among authors: weersink ejm. Expert Rev Respir Med. 2018 May;12(5):361-374. doi: 10.1080/17476348.2018.1457440. Epub 2018 Mar 29. Expert Rev Respir Med. 2018. PMID: 29575948 Review.
[Severe asthma in adults].
Weersink EJ, Braunstahl GJ, Roldaan AC. Weersink EJ, et al. Ned Tijdschr Geneeskd. 2013;157(19):A6232. Ned Tijdschr Geneeskd. 2013. PMID: 23657105 Review. Dutch.
Early and late asthmatic reaction after allergen challenge.
Weersink EJ, Postma DS, Aalbers R, de Monchy JG. Weersink EJ, et al. Respir Med. 1994 Feb;88(2):103-14. doi: 10.1016/0954-6111(94)90021-3. Respir Med. 1994. PMID: 8146407 Free article. Review. No abstract available.
75 results